| A Trial to Assess the Pharmacokinetics, Pharmacodynamics, and the Safety and Tolerability of Semaglutide in Healthy Male Japanese and Caucasian Subjects (NCT02146079) | Novo Nordisk A/S | 2014-05-21 |
| Efficacy and Safety of Lucentis® Use in Patients With Diabetic Macular Edema Evaluating a Spaced Out Follow-up After Intensive Treatment Phase (NCT02032173) | Novartis Pharmaceuticals | 2014-05-19 |
| Sardine-enriched Diet for Prevention Type 2 Diabetes (NCT03557541) | Institut d'Investigacions Biomèdiques August Pi i Sunyer | 2014-05-01 |
| A Randomised Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of Faster-acting Insulin Aspart in Subjects With Type 1 Diabetes (NCT02131246) | Novo Nordisk A/S | 2014-05-01 |
| A Dose-response of the Effects of Exendin-9,39 on GI Symptoms and Food Intake (NCT02128581) | Mayo Clinic | 2014-05-01 |
| Metabolomic Profiling in Adolescents With Obesity and Diabetes (NCT02145572) | University of California, San Diego | 2014-05-01 |
| Identification and Metabolic Characterization of a Cohort of Human Subjects With Mutations in PRDM-16 (NCT02808715) | National Heart Centre Singapore | 2014-05-01 |
| PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes (NCT02282423) | Mayo Clinic | 2014-05-01 |
| The Efficacy and Safety of Liraglutide Adjunct to Insulin Treatment in Type 1 Diabetes (NCT02098395) | Novo Nordisk A/S | 2014-05-01 |
| Simultaneous Risk Factor Control Using Telehealth to slOw Progression of Diabetic Kidney Disease (STOP-DKD) (NCT01829256) | Duke University | 2014-05-01 |
| ADA Linagliptin in Long Term Care (NCT02061969) | Emory University | 2014-04-25 |
| Family Health History in Diverse Care Settings (FHH) (NCT01956773) | Duke University | 2014-04-11 |
| Sodium Chloride and Contrast Nephropathy (NCT03476460) | Hospital Universitario Ramon y Cajal | 2014-04-01 |
| UTLight-transcranial Doppler Assessment of Regional Cerebral Autoregulation (NCT02178787) | Beth Israel Deaconess Medical Center | 2014-04-01 |
| A Trial Comparing Sequential Addition of Insulin Aspart Versus Further Dose Increase With Insulin Degludec/Liraglutide in Subjects With Type 2 Diabetes Mellitus, Previously Treated With Insulin Degludec/Liraglutide and Metformin and in Need of Further Intensification (NCT02100475) | Novo Nordisk A/S | 2014-04-01 |
| Comparison of Outreach Approaches to Increase Enrollment in a Healthy Cholesterol Study (NCT02086539) | University of Pennsylvania | 2014-04-01 |
| Tart Cherry, Metabolic Syndrome, and Cardiovascular Risk (NCT02154100) | Florida State University | 2014-04-01 |
| The Use of CGMS to Detect Alterations of Blood Glucose in Thalassemic Patients (NCT03591900) | Ain Shams University | 2014-04-01 |
| Study of a Community Based Approach to Control Cardiovascular Risk Factors in India (NCT02115711) | University Hospitals Cleveland Medical Center | 2014-04-01 |
| Effect of Vitamin D3 Supplementation on Cardiometabolic Risk (NCT02359214) | University of Chester | 2014-04-01 |
| The Belgian Diabetes in Pregnancy Study: BEDIP-N Study (NCT02036619) | Universitaire Ziekenhuizen KU Leuven | 2014-04-01 |
| Reverse Innovation and Patient Engagement to Improve Quality of Care and Patient Outcomes (NCT02222909) | Johns Hopkins Bloomberg School of Public Health | 2014-04-01 |
| Phase III Insulin Add-On Asia Regional Program - ST (NCT02096705) | AstraZeneca | 2014-03-31 |
| A Trial Comparing the Pharmacokinetic Properties of Faster-acting Insulin Aspart (FIAsp) After Different Injection Regions and Routes of Administration in Healthy Subjects (NCT02089451) | Novo Nordisk A/S | 2014-03-17 |
| OCT Screening for Diabetic Macular Edema at Primary Diabetes Care Visits (NCT01875783) | Joslin Diabetes Center | 2014-03-17 |
| Effect of Wet Cupping Versus Moderate Intensity Aerobic Exercise on Inflammatory Markers in Diabetic Patients (NCT06667648) | Deraya University | 2014-03-15 |
| Trial Investigating the Effect of Semaglutide on Energy Intake, Appetite Sensations, Postprandial Glucose and Triglyceride Metabolism and Gastric Emptying in Obese Subjects Compared With Placebo (NCT02079870) | Novo Nordisk A/S | 2014-03-06 |
| A Role for Brown Adipose Tissue in Postprandial Thermogenesis? (NCT01974778) | Bayside Health | 2014-03-01 |
| Influence of Diabetes on Lower Limb Amputation (NCT02500303) | University of Glasgow | 2014-03-01 |
| Liquid Protein Preloads With Different Carbohydrate Types Effects on the Glycaemic and Insulinaemic Response (NCT02151188) | Singapore Institute of Food and Biotechnology Innovation | 2014-03-01 |
| Taiwan Diabesity Study:Comparison With Mild Obese T2DM Patients Who Under Metabolic Surgery (NCT02166372) | Min-Sheng General Hospital | 2014-03-01 |
| Robust Evaluation to Measure Improvements in Nonadherence From Low-cost Devices (NCT02015806) | Brigham and Women's Hospital | 2014-03-01 |
| Evaluation of Optimal Dosing Conditions for GLP-1 Analogue NNC0113-0987 When Administered Orally in Healthy Male Subjects (NCT02094521) | Novo Nordisk A/S | 2014-03-01 |
| Effects of Different Types of Anesthesia on Stress Response in Laparoscopic Gastric Bypass for Type 2 Diabetes Mellitus (NCT01963546) | Guangzhou General Hospital of Guangzhou Military Command | 2014-03-01 |
| INtegrating DEPrEssioN and Diabetes treatmENT (INDEPENDENT) Study (NCT02022111) | Emory University | 2014-03-01 |
| Diabetes and Glycosylation in Cervical Spondylosis (NCT02758899) | Washington University School of Medicine | 2014-03-01 |
| The Mobile Health Platform (NCT02099513) | Duke University | 2014-03-01 |
| A Trial Investigating the Influence of Oral Semaglutide on the Pharmacokinetics of Lisinopril and Warfarin in Healthy Subjects (NCT02070510) | Novo Nordisk A/S | 2014-02-27 |
| A Retrospective Database Assessment of Clinical Effectiveness in Type 2 Diabetes Patients Treated With Liraglutide From Primary Care Centers in Sweden (NCT02077946) | Novo Nordisk A/S | 2014-02-10 |
| A Study to Evaluate the Performance of VibraTip® by Different Clinical Users (NCT01878682) | Tameside Hospital NHS Foundation Trust | 2014-02-06 |
| Influence of Bariatric Surgery on Serum Levels of 26RFa (NCT01982019) | University Hospital, Rouen | 2014-02-04 |
| Trial Investigating the Absorption, Metabolism and Excretion After a Single Subcutaneous Dose of [3H]-Semaglutide in Healthy Male Subjects (NCT02060266) | Novo Nordisk A/S | 2014-02-04 |
| Efficacy and Safety of Semaglutide Once-weekly Versus Placebo in Drug-naïve Subjects With Type 2 Diabetes (NCT02054897) | Novo Nordisk A/S | 2014-02-03 |
| Multi-Channel Automated Diet and Physical Activity Intervention for Pre-Diabetics (NCT01479062) | Berkeley Analytics, Inc. | 2014-02-01 |
| Sensor-based Balance Training in Diabetes: A Virtual Reality Paradigm (NCT02214329) | University of Arizona | 2014-02-01 |
| The Hong Kong Diabetes Biobank (NCT05282680) | Chinese University of Hong Kong | 2014-02-01 |
| Stem Cell Mobilization With Plerixafor in Diabetic vs Control Subjects (NCT02056210) | University of Padova | 2014-02-01 |
| Comparison of New-onset Diabetes After Transplantation Between Two Steroid Withdrawal Group With CellCept (NCT02095418) | Samsung Medical Center | 2014-02-01 |
| Effects of Electromagnetic Therapy Versus Laser Therapy on Peripheral Diabetic Neuropathy (NCT03049605) | Imam Abdulrahman Bin Faisal University | 2014-01-25 |
| Efficacy and Safety of Liraglutide Versus Sulphonylurea Both in Combination With Metformin During Ramadan in Subjects With Type 2 Diabetes (NCT01917656) | Novo Nordisk A/S | 2014-01-09 |
| A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, With or Without OADs in Subjects With Type 2 Diabetes (NCT02030600) | Novo Nordisk A/S | 2014-01-06 |
| A Trial Comparing the Safety and Efficacy of Insulin Degludec and Insulin Glargine, Both With Insulin Aspart as Mealtime Insulin in Subjects With Type 1 Diabetes (NCT02034513) | Novo Nordisk A/S | 2014-01-05 |
| Platelet Reactivity, B-amyloid, MOTS-c and Mortality of Type II Diabetics With CAD (NCT04027712) | University of Athens | 2014-01-01 |
| Role of Growth Hormone Antagonism in Modulating Insulin Sensitivity in Subjects With Pre-diabetes (NCT02023918) | University of California, San Francisco | 2014-01-01 |
| A Trial Investigating the Pharmacodynamic Response of Faster Acting Insulin Aspart in Subjects With Type 1 Diabetes (NCT02033239) | Novo Nordisk A/S | 2014-01-01 |
| Atrial Fibrillation Detected by Continuous ECG Monitoring (NCT02036450) | Rigshospitalet, Denmark | 2014-01-01 |
| A Study of Xuebi Formula for Diabetic Peripheral Neuropathy(Qi-deficiency and Blood-stasis) (NCT02039544) | Guang'anmen Hospital of China Academy of Chinese Medical Sciences | 2014-01-01 |
| Feasibility Study to Determine the Optimal Calibration Method for Glucose Sensors (NCT02155023) | Medical University of Graz | 2014-01-01 |
| Effectiveness of the Diabetes Conversation Map Program Among Diabetic Patients in Taiwan (NCT02733315) | Dalin Tzu Chi General Hospital | 2014-01-01 |
| Candida Albicans in Periodontal and Endodontic Lesions in Diabetic and Normoglycemic Patients (NCT02867254) | Universidade Federal Fluminense | 2014-01-01 |
| The Flamenco (Fitness League Against MENopause COsts) Project (NCT02358109) | Universidad de Granada | 2014-01-01 |
| Weight Loss and/or Exercise Training to Discover Muscle Lipids Related to Insulin Sensitivity (NCT02043405) | University of Colorado, Denver | 2014-01-01 |
| Evaluation of an Karajishi Contour Investigational Blood Glucose Monitoring System (NCT02041286) | Ascensia Diabetes Care | 2014-01-01 |
| Ketogenic Diet Treatment of Obesity With Co-morbid Type 2 Diabetes Mellitus and/or Obstructive Sleep Apnea (NCT02069197) | Mid-Atlantic Epilepsy and Sleep Center, LLC | 2014-01-01 |
| Social Forces to Improve Statin Adherence (Study A) (NCT02018809) | University of Pennsylvania | 2014-01-01 |
| Social Forces to Improve Statin Adherence (Study B) (NCT02148523) | University of Pennsylvania | 2014-01-01 |
| Short Messaging Service for Optimizing Hemoglobin A1C Management in Low-Income Diabetics (NCT02049359) | Campbell University, Incorporated | 2014-01-01 |
| The Alberta Vascular Risk Reduction Community Pharmacy Project: RxEACH (NCT01979471) | University of Alberta | 2014-01-01 |
| Evaluation of an Karajishi TS Investigational Blood Glucose Monitoring System (NCT02041377) | Ascensia Diabetes Care | 2014-01-01 |
| Influence of Semaglutide on Pharmacokinetics and Pharmacodynamics of Warfarin and Pharmacokinetics of Metformin in Healthy Subjects (NCT02022254) | Novo Nordisk A/S | 2013-12-17 |
| Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Hepatic Impairment (NCT02016911) | Novo Nordisk A/S | 2013-12-12 |
| Pharmacokinetics, Safety and Tolerability of Oral Semaglutide in Subjects With Various Degrees of Impaired Renal Function (NCT02014259) | Novo Nordisk A/S | 2013-12-11 |
| Efficacy and Safety of Switching From Sitagliptin to Liraglutide in Subjects With Type 2 Diabetes Not Achieving Adequate Glycaemic Control on Sitagliptin and Metformin (NCT01907854) | Novo Nordisk A/S | 2013-12-02 |
| Efficacy and Safety of Semaglutide Once-weekly Versus Sitagliptin Once-daily as add-on to Metformin and/or TZD in Subjects With Type 2 Diabetes (NCT01930188) | Novo Nordisk A/S | 2013-12-02 |
| Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes (NCT01923181) | Novo Nordisk A/S | 2013-12-02 |
| Take Charge of Your Diabetes (NCT01977495) | University of Pennsylvania | 2013-12-01 |
| Advanced Comprehensive Diabetes Care for Veterans With Poorly-Controlled Diabetes (NCT01778751) | VA Office of Research and Development | 2013-12-01 |
| The Efficacy and Safety of Liraglutide Compared to Sitagliptin, Both in Combination With Metformin in Chinese Subjects With Type 2 Diabetes (NCT02008682) | Novo Nordisk A/S | 2013-12-01 |
| Study of the Mechanisms of Metabolic Adaptations to Overfeeding (NCT02225457) | Centre Hospitalier Universitaire Vaudois | 2013-12-01 |
| Post Approval Study of the TS Feature With the 530G Pump System Supplemented With Commercial Patient Data (NCT02003898) | Medtronic MiniMed, Inc. | 2013-11-26 |
| Sunshine 2 Study for Women With Diabetes (NCT01904032) | Loyola University | 2013-11-21 |
| Investigating the Safety Profile of Liraglutide Under Normal Conditions of Use in Korean Subjects With Type 2 Diabetes Mellitus (NCT01821846) | Novo Nordisk A/S | 2013-11-20 |
| A Trial Evaluating Compatibility and Safety of FIAsp and Insulin Aspart With an External Continuous Subcutaneous Insulin Infusion System in Adult Subjects With Type 1 Diabetes (NCT01999322) | Novo Nordisk A/S | 2013-11-19 |
| Improving Autonomic Function and Balance in Diabetic Neuropathy (NCT01864460) | VA Office of Research and Development | 2013-11-14 |
| Studying the Effect of Capsinoids on Brown Fat Using Infrared Thermal Imaging. (NCT01961674) | Singapore Institute of Food and Biotechnology Innovation | 2013-11-01 |
| BNP Pharmacodynamics and Effects on Metabolism in Lean and Obese Subjects (NCT01977859) | AdventHealth Translational Research Institute | 2013-11-01 |
| TEAMcare for Diabetes in Mental Health Centers (NCT02011529) | University of Washington | 2013-11-01 |
| Peer-led, Empowerment-based, Approach to Self-management Efforts in Diabetes (NCT02661581) | University of British Columbia | 2013-11-01 |
| Effects of Interrupting Sedentary Time on Glycemic Control in Older Overweight and Obese Adults (NCT01997021) | University of Colorado, Denver | 2013-11-01 |
| A Trial to Assess the Efficacy and Safety of BioChaperone Combo and Humalog Mix 25 in Subjects With Type 1 Diabetes (NCT01981031) | Adocia | 2013-11-01 |
| A Trial Investigating the Pharmacokinetic and Pharmacodynamic Properties of FIAsp When Administered as a Bolus in a Continuous Subcutaneous Infusion Regimen in Subjects With Type 1 Diabetes (NCT01992588) | Novo Nordisk A/S | 2013-11-01 |
| Investigation on Safety, Tolerability and Pharmacokinetics of Multiple Doses of NNC0113-0987 in an Oral Formulation in Healthy Subjects (NCT01978613) | Novo Nordisk A/S | 2013-11-01 |
| A Mixed Methods Approach to the Development and Testing of the Measure of Drug Self-Management (MeDS) (NCT01998269) | University of North Carolina, Chapel Hill | 2013-11-01 |
| The Efficacy and Safety of Liraglutide as Adjunct Therapy to Insulin in the Treatment of Type 1 Diabetes (NCT01836523) | Novo Nordisk A/S | 2013-11-01 |
| Is a Smartphone Application Effective as an Oral Medication Adherence Aid (NCT01968876) | University of Arkansas | 2013-10-30 |
| A Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Subjects With Type 2 Diabetes at High Risk of Cardiovascular Events (NCT01959529) | Novo Nordisk A/S | 2013-10-29 |
| A Trial Investigating the Efficacy and Safety of Insulin Degludec/Insulin Aspart Once Daily Plus Insulin Aspart for the Remaining Meals Versus Insulin Detemir Once or Twice Daily Plus Meal Time Insulin Aspart in Children and Adolescents With Type 1 Diabetes Mellitus (NCT01835431) | Novo Nordisk A/S | 2013-10-17 |
| Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients (NCT02158442) | Osprey Medical, Inc | 2013-10-01 |
| Investigation on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Doses of a Long Acting GLP-1 Analogue (NNC0113-0987) in Healthy Male Subjects (NCT01967589) | Novo Nordisk A/S | 2013-10-01 |
| Insulin Dosing in Diabetic Patients With End Stage Renal Disease (ESRD) or Hemodialysis (NCT02083133) | Cook County Health | 2013-10-01 |